menu
    • menu

    Company profile for NeoGenomics

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NeoGenomics is a premier cancer diagnostic, pharma services, and information services company serving oncologists, pathologists, pharmaceutical companies, and academic centers in their pursuit of providing better futures for people living with cancer.Our vision brings together uncompromising quality, exceptional service, and innovative solutions. Each member of our team is committed to our mission: Save lives by improving pati...
    NeoGenomics is a premier cancer diagnostic, pharma services, and information services company serving oncologists, pathologists, pharmaceutical companies, and academic centers in their pursuit of providing better futures for people living with cancer.Our vision brings together uncompromising quality, exceptional service, and innovative solutions. Each member of our team is committed to our mission: Save lives by improving patient CARE through Communication, Accuracy, Reliability, and Efficiency.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeoGenomicsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9490 NeoGenomics Way Fort Myers, FL 33912
    Telephone
    Telephone
    239.768.0600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://neogenomics.com/about
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neogenomics-laboratories/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/NeoGenomics

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neogenomics' Pantracer Lbx Receives Medicare Coverage, Expanding
    Neogenomics' Pantracer Lbx Receives Medicare Coverage, Expanding

    16 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260316411589/en/NeoGenomics-PanTracer-LBx-Receives-Medicare-Coverage-Expanding-Access-to-Comprehensive-Liquid-Biopsy-Profiling

    BUSSINESSWIRE
    16 Mar 2026
    Share Share
    NeoGenomics Launches RaDaR ST for Solid Tumors Type
    NeoGenomics Launches RaDaR ST for Solid Tumors Type

    25 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-25/neogenomics-launches-radar-st-expanding-molecular-residual-disease-testing-across-multiple-solid-tu

    PHARMIWEB
    25 Feb 2026
    Share Share
    NeoGenomics To Participate In Upcoming Investor Conferences
    NeoGenomics To Participate In Upcoming Investor Conferences

    18 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260218686355/en/NeoGenomics-to-Participate-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    18 Feb 2026
    Share Share
    NeoGenomics Reports Fourth Quarter And Full Year 2025 Results
    NeoGenomics Reports Fourth Quarter And Full Year 2025 Results

    17 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-17/neogenomics-reports-fourth-quarter-and-full-year-2025-results

    PHARMIWEB
    17 Feb 2026
    Share Share
    NeoGenomics Launches PanTracer Pro For Solid Tumor Therapy
    NeoGenomics Launches PanTracer Pro For Solid Tumor Therapy

    12 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-12/neogenomics-introduces-pantracer-pro-to-support-timely-informed-solid-tumor-therapy-selection

    PHARMIWEB
    12 Feb 2026
    Share Share
    NeoGenomics To Release Q4 And Full Year 2025 Financial Results
    NeoGenomics To Release Q4 And Full Year 2025 Financial Results

    27 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260127745368/en/NeoGenomics-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-17-2026

    BUSINESSWIRE
    27 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search